Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 403291, 8 pages
http://dx.doi.org/10.1155/2015/403291
Research Article

Cardioprotective Activity of Pongamia pinnata in Streptozotocin-Nicotinamide Induced Diabetic Rats

1Department of Pharmacology, PES’s Modern College of Pharmacy, Sector 21, Yamuna Nagar, Nigadi, Pune 411 044, India
2Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Paud Road, Erandwane, Pune 411 038, India

Received 17 February 2015; Revised 29 March 2015; Accepted 30 March 2015

Academic Editor: Kazim Husain

Copyright © 2015 Sachin L. Badole et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Maya and F. J. Villarreal, “Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 3, pp. 524–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Wang, Y. Song, Q. Wang, P. M. Kralik, and P. N. Epstein, “Causes and characteristics of diabetic cardiomyopathy,” The Review of Diabetic Studies, vol. 3, no. 3, pp. 108–117, 2006. View at Publisher · View at Google Scholar
  3. Y. F. Zhi, J. B. Prins, and T. H. Marwick, “Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications,” Endocrine Reviews, vol. 25, no. 4, pp. 543–567, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. W. B. Kannel, M. Hjortland, and W. P. Castelli, “Role of diabetes in congestive heart failure: the Framingham study,” The American Journal of Cardiology, vol. 34, no. 1, pp. 29–34, 1974. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Boudina and E. D. Abel, “Diabetic cardiomyopathy revisited,” Circulation, vol. 115, no. 25, pp. 3213–3223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Sulaiman, M. J. Matta, N. R. Sunderesan, M. P. Gupta, and M. Periasamy, “Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 3, pp. H833–H843, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Murarka and M. R. Movahed, “Diabetic cardiomyopathy,” Journal of Cardiac Failure, vol. 16, no. 12, pp. 971–979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Krishnamurthi, The Wealth of India—Raw Materials: Ph-Re, vol. 8, Publication and Information Directorate, Council of Scientific and Industrial Research, New Delhi, India, 1998.
  11. S. L. Badole and L. Bodhankar, “Antihyperglycemic activity of Pongamia pinnata stem bark in diabetic mice,” Pharmaceutical Biology, vol. 46, no. 12, pp. 900–905, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. L. Badole and S. L. Bodhankar, “Investigation of antihyperglycaemic activity of aqueous and petroleum ether extract of stem bark of Pongamia pinnata on serum glucose level in diabetic mice,” Journal of Ethnopharmacology, vol. 123, no. 1, pp. 115–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. L. Badole and S. L. Bodhankar, “Concomitant administration of petroleum ether extract of the stem bark of Pongamia pinnata (L.) Pierre with synthetic oral hypoglycaemic drugs in alloxan-induced diabetic mice,” European Journal of Integrative Medicine, vol. 1, no. 2, pp. 73–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L. Badole and S. L. Bodhankar, “Antihyperglycaemic activity of cycloart-23-ene-3β, 25-diol isolated from stem bark of Pongamia pinnata in alloxan induced diabetic mice,” Research Journal of Phytochemistry, vol. 3, no. 1, pp. 18–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. L. Badole and S. L. Bodhankar, “Antidiabetic activity of cycloart-23-ene-3β, 25-diol (B2) isolated from Pongamia pinnata (L. Pierre) in streptozotocin-nicotinamide induced diabetic mice,” European Journal of Pharmacology, vol. 632, no. 1–3, pp. 103–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. L. Badole, P. P. Bagul, S. P. Mahamuni et al., “Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats,” Chemico-Biological Interactions, vol. 203, no. 2, pp. 530–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. L. Badole, S. L. Bodhankar, and C. G. Raut, “Protective effect of cycloart-23-ene-3β, 25-diol (B2) isolated from Pongamia pinnata L. Pierre on vital organs in streptozotocin-nicotinamide induced diabetic mice,” Asian Pacific Journal of Tropical Biomedicine, vol. 1, supplement, no. 2, pp. S186–S190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. T. F. Slater and B. C. Sawyer, “The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used,” Biochemical Journal, vol. 123, no. 5, pp. 805–814, 1971. View at Google Scholar
  19. M. S. Moron, J. W. Depierre, and B. Mannervik, “Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver,” Biochimica et Biophysica Acta, vol. 582, no. 1, pp. 67–78, 1979. View at Publisher · View at Google Scholar · View at Scopus
  20. H. P. Misra and I. Fridovich, “The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase,” The Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972. View at Google Scholar · View at Scopus
  21. O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randell, “Protein measurement with the folin phenol reagent,” The Journal of biological chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  22. S. Xi, G. Zhou, X. Zhang, W. Zhang, L. Cai, and C. Zhao, “Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms,” Experimental and Molecular Medicine, vol. 41, no. 8, pp. 538–547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Li, Y. Gu, Y. Song et al., “Cardiac functional analysis by electrocardiography, echocardiography and in situ hemodynamics in streptozotocin-induced diabetic mice,” Journal of Health Science, vol. 50, no. 4, pp. 356–365, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Qin, B. Huang, L. Deng et al., “Downregulation of K+ channel genes expression in type I diabetic cardiomyopathy,” Biochemical and Biophysical Research Communications, vol. 283, no. 3, pp. 549–553, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Wichi, C. Malfitano, K. Rosa et al., “Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents,” Cardiovascular Diabetology, vol. 6, article 14, 8 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Yamaguchi, Y. Higuchi, S. Hirotani et al., “Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15883–15888, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. G. R. Borges, M. de Oliveira, H. C. Salgado, and R. Fazan Jr., “Myocardial performance in conscious streptozotocin diabetic rats,” Cardiovascular Diabetology, vol. 5, article 26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Sun, M. Shen, J. Li et al., “Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy,” Cardiovascular Diabetology, vol. 10, article 4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Edet, M. Akpanabiatu, A. Eno, I. Umoh, and E. Itam, “Effect of Gongronema latifolium crude leaf extract on some cardiac enzymes of alloxan- induced diabetic rats,” African Journal of Biochemistry Research, vol. 3, pp. 366–369, 2009. View at Google Scholar
  30. L. Cai and Y. J. Kang, “Oxidative stress and diabetic cardiomyopathy: a brief review,” Cardiovascular Toxicology, vol. 1, no. 3, pp. 181–193, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Moussa, “Oxidative stress in diabetes mellitus,” Romanian Journal of Biophysics, vol. 18, pp. 225–236, 2008. View at Google Scholar
  33. L. Cai, J. Wang, Y. Li et al., “Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy,” Diabetes, vol. 54, no. 6, pp. 1829–1837, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. E. E. Farmer and C. Davoine, “Reactive electrophile species,” Current Opinion in Plant Biology, vol. 10, no. 4, pp. 380–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Del Rio, A. J. Stewart, and N. Pellegrini, “A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 4, pp. 316–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Hamblin, D. B. Friedman, S. Hill, R. M. Caprioli, H. M. Smith, and M. F. Hill, “Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 4, pp. 884–895, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Akula, M. K. Kota, S. G. Gopisetty et al., “Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats,” Pharmacological Research, vol. 48, no. 5, pp. 429–435, 2003. View at Publisher · View at Google Scholar · View at Scopus